Ondrová K., Zůvalová I., Vyhlídalová B., Krasulová K., Miková E., Vrzal R., Nádvorník P., Kopečná M., Kopečný D., Šebela M., Soural M., Dvořák Z. Monoterpenoid aryl hydrocarbon receptor allosteric antagonists protect against ultraviolet skin damage in female mice. Nature Communications. 2023.

Karasová M., Procházková J., Tylichová Z., Dvořák Z., Vyhlídalová B., Zůvalová I., Ehrmann J., Bouchal J. Inhibition of Aryl Hydrocarbon Receptor (AhR) Expression Disrupts Cell Proliferation and Alters Energy Metabolism and Fatty Acid Synthesis in Colon Cancer Cells. Cancers. 2022.

Grycová A., Hansol J., Maier V., Illés P., Vyhlídalová B., Poulíková K., Sládeková L., Nádvorník P., Vrzal R., Zemánková L., Pečinková P., Poruba M., Zapletalová I., Večeřa R., Anzenbacher P., Ehrmann J., Ondra P., Jung J., Mani S., Dvořák Z. Targeting the Aryl Hydrocarbon Receptor with Microbial Metabolite Mimics Alleviates Experimental Colitis in Mice. JOURNAL OF MEDICINAL CHEMISTRY. 2022.

Vyhlídalová B., Krasulová K., Pečinková P., Poulíková K., Vrzal R., Andrysík Z., Chandran A., Mani S., Dvořák Z. Antimigraine Drug Avitriptan Is a Ligand and Agonist of Human Aryl Hydrocarbon Receptor that Induces CYP1A1 in Hepatic and Intestinal Cells. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2020.

Vyhlídalová B., Zůvalová I., Jiskrová E., Li H., Mani S., Dvořák Z. Differential activation of human pregnane X receptor PXR by isomeric mono-methylated indoles in intestinal and hepatic in vitro models. TOXICOLOGY LETTERS. 2020.

Vyhlídalová B., Krasulová K., Pečinková P., Marcalíková A., Vrzal R., Zemánková L., Vančo J., Trávníček Z., Vondráček J., Karasová M., Mani S., Dvořák Z. Gut Microbial Catabolites of Tryptophan Are Ligands and Agonists of the Aryl Hydrocarbon Receptor: A Detailed Characterization. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2020.

Illés P., Krasulová K., Vyhlídalová B., Poulíková K., Marcalíková A., Pečinková P., Sirotová N., Vrzal R., Mani S., Dvořák Z. Indole microbial intestinal metabolites expand the repertoire of ligands and agonists of the human pregnane X receptor. TOXICOLOGY LETTERS. 2020.

Dvořák Z., Kopp F., Costello CM., Vrzalová A., Štěpánková M., Zůvalová I., Jiskrová E., Poulíková K., Vyhlídalová B. Targeting the pregnane X receptor using microbial metabolite mimicry. EMBO Molecular Medicine. 2020.

Abbott KL., Chaudhury ChS., Chandran A., Dvořák Z., Jiskrová E., Poulíková K., Vyhlídalová B. Belinostat, at Its Clinically Relevant Concentrations, Inhibits Rifampicin-Induced CYP3A4 and MDR1 Gene Expression. MOLECULAR PHARMACOLOGY. 2019.

Vyhlídalová B., Poulíková K., Bartoňková I., Krasulová K., Vančo J., Trávníček Z., Mani S., Dvořák Z. Mono-methylindoles induce CYP1A genes and inhibit CYP1A1 enzyme activity in human hepatocytes and HepaRG cells. TOXICOLOGY LETTERS. 2019.